{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:59:27Z","timestamp":1793170767459,"version":"4.5.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Adamas Pharmaceuticals, Inc"},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biotie Therapies"},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Civitas\/Acorda Therapeutics"},{"DOI":"10.13039\/100014427","name":"Dystonia Coalition","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Huntington Study Group"},{"name":"Kyowa Haako Kirin Pharma, Inc"},{"name":"Medtronic Neuromodulation"},{"DOI":"10.13039\/501100013116","name":"Merz Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014593","name":"Neurocrine Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NeuroDerm Ltd"},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nuvelution"},{"DOI":"10.13039\/100014275","name":"Parkinson Study Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prothena Biosciences Inc"},{"DOI":"10.13039\/100014484","name":"Psyadon Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014484","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Revance Therapeutics, Inc"},{"name":"Sangamo BioSciences, Inc"},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.parkreldis.2019.06.025","type":"journal-article","created":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T09:25:09Z","timestamp":1561886709000},"page":"74-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Juvenile parkinsonism: Differential diagnosis, genetics, and treatment"],"prefix":"10.1016","volume":"67","author":[{"given":"Nicki","family":"Niemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.06.025_bib1","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.52.6.1214","article-title":"Incidence and distribution of parkinsonism in Olmsted county, Minnesota, 1976-1990","volume":"52","author":"Bower","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson's disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.parkreldis.2018.03.030","article-title":"Descriptive epidemiology of parkinsonism in the Canton of Geneva, Switzerland","volume":"54","author":"Fleury","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archneurol.2010.194","article-title":"Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study","volume":"67","author":"Alcalay","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.06.001","article-title":"Young-onset Parkinson's disease: Its unique features and their impact on quality of life","author":"Mehanna","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(06)70411-2","article-title":"Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism","volume":"5","author":"Schrag","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/11533130-000000000-00000","volume":"24","author":"Thomsen","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.870020201","article-title":"Young onset Parkinson's disease","volume":"2","author":"Quinn","year":"1987","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.870130605","article-title":"Young-onset Parkinson's disease revisited\u2014clinical features, natural history, and mortality","volume":"13","author":"Schrag","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib16","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.27193","article-title":"Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature","volume":"32","author":"Schneider","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/mds.27352","article-title":"Genotype-phenotype relations for the Parkinson's disease genes parkin, PINK1, DJ1: MDSGene systematic review","volume":"33","author":"Kasten","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/WNL.42.5.1124","article-title":"Juvenile-onset parkinsonism: same patient reported twice","volume":"42","author":"Jellinger","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib19","first-page":"91","article-title":"Juvenile parkinsonism: a case with first clinical manifestation at the age of six years and with neuropathological findings suggesting a new pathogenesis","volume":"10","author":"Mizutani","year":"1991","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1212\/WNL.41.6.820","article-title":"New pathologic observations in juvenile onset parkinsonism with dystonia","volume":"41","author":"Gibb","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1468-1331.2000.t01-1-00100.x","article-title":"Juvenile parkinsonism: a heterogeneous entity","volume":"7","author":"Cardoso","year":"2000","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.parkreldis.2017.02.025","article-title":"Parkinsonian-Pyramidal syndromes: a systematic review","volume":"39","author":"Tranchant","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","article-title":"The genetic landscape of Parkinson's disease","volume":"174","author":"Lunati","year":"2018","journal-title":"Rev. Neurol. (Paris)."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-017-0780-8","article-title":"New genes causing hereditary Parkinson's disease or parkinsonism","volume":"17","author":"Puschmann","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib25","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mds.26527","article-title":"Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mds.27140","article-title":"Treatable inherited rare movement disorders","volume":"33","author":"Jinnah","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib27","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s40142-017-0116-7","article-title":"Counseling at-risk Parkinson's disease cohorts: integrating emerging evidence","volume":"5","author":"Sokol","year":"2017","journal-title":"Curr. Genet. Med. Rep."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ceb.2017.03.013","article-title":"PINK1 and Parkin: emerging themes in mitochondrial homeostasis","volume":"45","author":"McWilliams","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncpneuro0126","article-title":"The genetics of Parkinson disease: implications for neurological care","volume":"2","author":"Klein","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib31","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1056\/NEJM200005253422103","article-title":"Association between early-onset Parkinson's disease and mutations in the parkin gene","volume":"342","author":"L\u00fccking","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib32","series-title":"MDSGene","author":"Parkinson","year":"2019"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-2002-4506","article-title":"Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation","volume":"4","author":"S\u00e1nchez","year":"2002","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/mds.20690","article-title":"Co-occurrence of restless legs syndrome and Parkin mutations in two families","volume":"21","author":"Adel","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/mds.22711","article-title":"Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations","volume":"24","author":"Limousin","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib36","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ajmg.b.30988","article-title":"Parkin gene modifies the effect of RLS4 on the age at onset of restless legs syndrome (RLS)","volume":"153","author":"Pichler","year":"2010","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mds.21262","article-title":"Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study","volume":"22","author":"Pellecchia","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archneur.64.3.421","article-title":"A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations","volume":"64","author":"Deng","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2019.01.010","article-title":"Diagnostic delay in Parkinson's disease caused by PRKN mutations (epub ahead of print)","author":"Ruiz-Lopez","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pjnns.2016.07.013","article-title":"Dopa-responsive dystonia or early-onset Parkinson disease \u2013 genotype\u2013phenotype correlation","volume":"51","author":"Potulska-Chromik","year":"2017","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/brainsci7070071","article-title":"Phenotypic discordance in siblings with identical compound heterozygous PARK2 mutations","volume":"7","author":"Isaacs","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib42","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/awg142","article-title":"Parkin disease: a phenotypic study of a large case series","volume":"126","author":"Khan","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.irn.2017.05.030","article-title":"Nonmotor signs in genetic forms of Parkinson's disease","volume":"133","author":"Kasten","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/ane.12538","article-title":"PRoBaND Investigators, Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients","volume":"134","author":"Malek","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.680","article-title":"Olfaction in Parkin carriers in Chinese patients with Parkinson disease","volume":"7","author":"Wang","year":"2017","journal-title":"Brain Behav"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib46","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1093\/brain\/awf237","article-title":"Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study","volume":"125","author":"Khan","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib47","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.parkreldis.2015.01.005","article-title":"A Peruvian family with a novel PARK2 mutation: clinical and pathological characteristics","volume":"21","author":"Cornejo-Olivas","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069190","article-title":"Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis","volume":"8","author":"McNeill","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib49","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/01.WNL.0000145765.19094.94","article-title":"Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease","volume":"63","author":"Varrone","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib50","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.2967\/jnumed.109.063529","article-title":"French Parkinson's Disease Genetics Study Group, A multitracer dopaminergic PET study of young-onset parkinsonian patients with and without parkin gene mutations","volume":"50","author":"Ribeiro","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/01.WNL.0000148725.48740.6D","article-title":"Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation","volume":"64","author":"Khan","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib52","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.irn.2017.01.009","article-title":"Genetics of Parkinson's disease: genotype\u2013phenotype correlations","volume":"132","author":"Koros","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib54","series-title":"Handb. Clin. Neurol.","first-page":"211","article-title":"Genetics of Parkinson disease","author":"Domingo","year":"2018"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/brain\/aww261","article-title":"Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism","volume":"140","author":"Puschmann","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib56","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/mds.22816","article-title":"Olfactory dysfunction in Parkinsonism caused by PINK1 mutations","volume":"24","author":"Ferraris","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib57","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.24346","article-title":"Defining neurodegeneration on Guam by targeted genomic sequencing","volume":"77","author":"Steele","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib59","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1212\/WNL.0000000000002744","article-title":"Absence of Lewy pathology associated with PINK1 homozygous mutation","volume":"86","author":"Takanashi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib60","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/ejn.12872","article-title":"Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1","volume":"41","author":"van der Merwe","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib61","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science (80-. )"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib62","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/brain\/aww080","article-title":"DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology","volume":"139","author":"Taipa","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib63","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007614","article-title":"Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss","author":"Narendra","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib64","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","article-title":"Skin nerve -synuclein deposits: a biomarker for idiopathic Parkinson disease","volume":"82","author":"Donadio","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib65","doi-asserted-by":"crossref","first-page":"29654","DOI":"10.1074\/jbc.M111.233874","article-title":"Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein","volume":"286","author":"Tan","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib66","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40246-019-0203-9","article-title":"Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion","volume":"13","author":"Spataro","year":"2019","journal-title":"Hum. Genom."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/brain\/aww307","article-title":"Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78)","volume":"140","author":"Estrada-Cuzcano","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0404.1994.tb02645.x","article-title":"Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome","volume":"89","author":"Najim al-Din","year":"1994","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib69","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/mds.20511","article-title":"Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia","volume":"20","author":"Williams","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib70","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/mds.22996","article-title":"Clinical spectrum of Kufor-Rakeb syndrome in the Chilean kindred with ATP13A2 mutations","volume":"25","author":"Behrens","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib71","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib72","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/mds.22947","article-title":"ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation","volume":"25","author":"Schneider","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.parkreldis.2010.10.011","article-title":"Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation","volume":"17","author":"Crosiers","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib74","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib75","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/01.wnl.0000310427.72236.68","article-title":"PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype","volume":"70","author":"Ning","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10048-010-0259-0","article-title":"Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability","volume":"12","author":"Santoro","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib77","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1432-1327.1999.00418.x","article-title":"The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene","volume":"262","author":"Larsson Forsell","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14802\/jmd.14034","article-title":"Neurodegeneration with brain iron accumulation: diagnosis and management","volume":"8","author":"Hogarth","year":"2015","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012897","article-title":"Catalytic function of PLA2G6 is impaired by mutations associated with infantile neuroaxonal dystrophy but not dystonia-parkinsonism","volume":"5","author":"Engel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5334\/tohm.254","article-title":"PLA2G6-associated dystonia-parkinsonism: case report and literature review","volume":"5","author":"Karkheiran","year":"2015","journal-title":"Tremor Other Hyperkinet Mov (N Y)K."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib81","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5334\/tohm.289","article-title":"PLA2G6 mutations related to distinct phenotypes: a new case with early-onset parkinsonism","volume":"6","author":"Giri","year":"2016","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s13104-016-2102-7","article-title":"Clinical heterogeneity of PLA2G6-related Parkinsonism: analysis of two Saudi families","volume":"9","author":"Bohlega","year":"2016","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib83","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-016-1658-7","article-title":"Mutation screening of PLA2G6 in Japanese patients with early onset dystonia-parkinsonism","volume":"124","author":"Yamashita","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib84","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ana.21415","article-title":"Characterization of PLA2G6 as a locus for dystonia-parkinsonism","volume":"65","author":"Paisan-Ruiz","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib85","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/mds.26814","article-title":"PLA2G6 mutations and Parkinsonism: long-term follow-up of clinical features and neuropathology","volume":"31","author":"Klein","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib86","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/WNL.0b013e3181f73649","article-title":"Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism","volume":"75","author":"Yoshino","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.0b013e318221acd3","article-title":"PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohort","volume":"77","author":"Shi","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib88","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2013.10.016","article-title":"Oculogyric crises induced by levodopa in PLA2G6 parkinsonism-dystonia","volume":"20","author":"Virmani","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1468-1331.2008.02356.x","article-title":"R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family","volume":"16","author":"Sina","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib90","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.parkreldis.2015.01.012","article-title":"Homozygous p.D331Y mutation in PLA2G6 in two patients with pure autosomal-recessive early-onset parkinsonism: further evidence of a fourth phenotype of PLA2G6-associated neurodegeneration","volume":"21","author":"Xie","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib91","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.b.32012","article-title":"PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson's disease","volume":"159B","author":"Lu","year":"2012","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib92","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/mds.25160","article-title":"Imaging striatal dopaminergic function in Phospholipase A2 Group VI -related parkinsonism","volume":"27","author":"Agarwal","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib93","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fneur.2018.00536","article-title":"Heterozygous PLA2G6 mutation leads to iron accumulation within basal ganglia and Parkinson's disease","volume":"9","author":"Ferese","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/jamaneurol.2013.572","article-title":"J. Jankovic, F-box only protein 7 gene in parkinsonian-pyramidal disease","volume":"70","author":"Deng","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib95","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/01.wnl.0000338144.10967.2b","article-title":"FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome","volume":"72","author":"Fonzo","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib96","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.parkreldis.2014.06.024","article-title":"A new Turkish family with homozygous FBXO7 truncating mutation and juvenile atypical parkinsonism","volume":"20","author":"Yalcin-Cakmakli","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib97","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.ajhg.2008.05.005","article-title":"Genome-wide linkage analysis of a parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays","volume":"82","author":"Shojaee","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib98","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.parkreldis.2014.07.016","article-title":"FBXO7\u2013R498X mutation: phenotypic variability from chorea to early onset parkinsonism within a family","volume":"20","author":"G\u00fcnd\u00fcz","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib99","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1073\/pnas.1000738107","article-title":"Endocytosis and clathrin-uncoating defects at synapses of auxilin knockout mice","volume":"107","author":"Yim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036458","article-title":"A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating Co-chaperone auxilin, is associated with juvenile parkinsonism","volume":"7","author":"Edvardson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib101","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ana.24553","article-title":"DNAJC6 mutations associated with early-onset Parkinson's disease","volume":"79","author":"Olgiati","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.parkreldis.2012.11.006","article-title":"DNAJC6 is responsible for juvenile parkinsonism with phenotypic variability","volume":"19","author":"K\u00f6ro\u011flu","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib103","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ana.24591","article-title":"A novel nonsense mutation in DNAJC 6 expands the phenotype of autosomal-recessive juvenile-onset Parkinson's disease","volume":"79","author":"Elsayed","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib104","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","author":"Di Paolo","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12031-018-1167-2","article-title":"A novel SYNJ1 mutation in a Tunisian family with juvenile Parkinson's disease associated with epilepsy","volume":"66","author":"Ben Romdhan","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib106","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/humu.22372","article-title":"The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive parkinsonism with generalized seizures","volume":"34","author":"Krebs","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10048-014-0406-0","article-title":"PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family","volume":"15","author":"Olgiati","year":"2014","journal-title":"Neurogenetics"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib108","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s12035-017-0535-1","article-title":"A clinical and molecular genetic study of 50 families with autosomal recessive parkinsonism revealed known and novel gene mutations","volume":"55","author":"Taghavi","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib109","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2016.07.014","article-title":"Identification of a novel homozygous mutation Arg459Pro in SYNJ1 gene of an Indian family with autosomal recessive juvenile Parkinsonism","volume":"31","author":"Kirola","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib110","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/humu.22373","article-title":"Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism","volume":"34","author":"Quadri","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012003","article-title":"Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation","volume":"5","author":"Vitureira","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib112","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmedgenet-2015-103459","article-title":"Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism","volume":"53","author":"Sudhaman","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib113","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.26627","article-title":"Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction","volume":"31","author":"Jaberi","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib114","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.26824","article-title":"PTRHD1 (C2orf79) mutations lead to autosomal-recessive intellectual disability and parkinsonism","volume":"32","author":"Khodadadi","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib115","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.27501","article-title":"PTRHD1 Loss-of-function mutation in an african family with juvenile-onset Parkinsonism and intellectual disability","volume":"33","author":"Kuipers","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/mds.26682","article-title":"VPS13C -another hint at mitochondrial dysfunction in familial Parkinson's disease","volume":"31","author":"Schreglmann","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib117","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/mds.27516","article-title":"Identification of a large homozygous VPS13C deletion in a patient with early-onset Parkinsonism","volume":"33","author":"Darvish","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib118","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/mds.27527","article-title":"Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review","volume":"33","author":"Trinh","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib119","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fneur.2018.01021","article-title":"SNCA multiplication investigators of the GEoPD consortium, a meta-analysis of \u03b1-synuclein multiplication in familial parkinsonism","volume":"9","author":"Book","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib120","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005660","article-title":"International Research Group on 22q11.2DS-associated Parkinson's Disease, Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2","volume":"90","author":"Boot","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib121","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamaneurol.2013.3646","article-title":"Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications","volume":"70","author":"Butcher","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib122","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia\u2014clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib123","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2008.155861","article-title":"Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients","volume":"80","author":"Trender-Gerhard","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib124","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s13312-016-0868-2","article-title":"Delayed diagnosis of dopa responsive dystonia in two siblings","volume":"53","author":"Jain","year":"2016","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0887-8994(94)90109-0","article-title":"Dopa-responsive dystonia simulating cerebral palsy","volume":"11","author":"Nygaard","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2004.03.017","article-title":"Misdiagnoses in children with dopa-responsive dystonia","volume":"31","author":"Jan","year":"2004","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib127","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/jpn.JPN_123_16","article-title":"Dopa-responsive dystonia in a child misdiagnosed as cerebral palsy","volume":"12","author":"Kulshreshtha","year":"2017","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib128","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/mdc3.12361","article-title":"A systematic review of treatment outcome in patients with dopa-responsive dystonia (DRD) and DRD-plus","volume":"3","author":"Kim","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib129","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1212\/WNL.0000000000003897","article-title":"L -Dopa in dystonia: a modern perspective","volume":"88","author":"Maas","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib130","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.43.8.1563","article-title":"Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia","volume":"43","author":"Turjanski","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib131","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.870120330","article-title":"[123I]beta-CIT single-photon emission tomography in DOPA-responsive dystonia","volume":"12","author":"Naumann","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib132","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.410350405","article-title":"Dopa-responsive dystonia: pathological and biochemical observations in a case","volume":"35","author":"Rajput","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib133","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1212\/WNL.53.5.1032","article-title":"Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia","volume":"53","author":"Furukawa","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib134","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/brain\/awu179","article-title":"International Parkinson's Disease Genomics Consortium and UCL-exomes consortium, Parkinson's disease in GTP cyclohydrolase 1 mutation carriers","volume":"137","author":"Mencacci","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2013.01.001","article-title":"Pitfalls in phenylalanine loading test in the diagnosis of dopa-responsive dystonia","volume":"108","author":"Opladen","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib136","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/WNL.48.5.1290","article-title":"Oral phenylalanine loading in dopa-responsive dystonia: a possible diagnostic test","volume":"48","author":"Hyland","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib137","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/WNL.0000000000003896","article-title":"Clinical pearls and scientific advancement","volume":"88","author":"Augustine","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib138","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/brain\/awl340","article-title":"The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene","volume":"130","author":"Brashear","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib139","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1212\/WNL.0000000000000212","article-title":"The expanding clinical and genetic spectrum of ATP1A3-related disorders","volume":"82","author":"Rosewich","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuron.2004.06.028","article-title":"Mutations in the Na+\/K+-ATPase \u03b13 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism","volume":"43","author":"de Carvalho Aguiar","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib141","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/ene.12650","article-title":"Isolated and combined dystonia syndromes - an update on new genes and their phenotypes","volume":"22","author":"Balint","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib142","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-014-1279-x","article-title":"Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings","volume":"128","author":"Oblak","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib143","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/brainsci7070072","article-title":"Clinicopathological phenotype and genetics of X-linked dystonia\u2013parkinsonism (XDP; DYT3; Lubag)","volume":"7","author":"Kawarai","year":"2017","journal-title":"Brain Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib144","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00207454.2010.526728","article-title":"The unique phenomenology of sex-linked dystonia parkinsonism (XDP, DYT3, \u201cLubag\u201d)","volume":"121","author":"Lee","year":"2011","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib145","first-page":"1246","article-title":"Wilson disease, Contin. Lifelong learn","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib146","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-018-0018-3","article-title":"Wilson disease","volume":"4","author":"Cz\u0142onkowska","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib147","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05109.x","article-title":"Neurologic Wilson's disease","volume":"1184","author":"Lorincz","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib148","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.parkreldis.2019.02.016","article-title":"Wilson's disease: a master of disguise","volume":"59","author":"Hedera","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib149","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/17469899.2018.1513328","article-title":"Neuro-ophthalmology of movement disorders","volume":"13","author":"Waln","year":"2018","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2012.09.013","article-title":"Characteristics of neurological Wilson's disease without Kayser\u2013Fleischer ring","volume":"323","author":"Youn","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib151","first-page":"234","article-title":"Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease","volume":"24","author":"Barthel","year":"2003","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib152","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5334\/tohm.435","article-title":"Advances in treatment of Wilson disease","volume":"8","author":"Aggarwal","year":"2018","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib153","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/13543784.2018.1482274","article-title":"WTX101 - an investigational drug for the treatment of Wilson disease","volume":"27","author":"Weiss","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib154","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2018.09.022","article-title":"A quarter century of progress since the gene discovery","volume":"396","author":"Testa","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib155","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/mds.25172","article-title":"Huntington's disease: how intermediate are intermediate repeat lengths?","volume":"27","author":"Squitieri","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib156","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(18)30294-1","article-title":"Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis","volume":"17","author":"Fusilli","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib157","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/mds.25237","article-title":"Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort","volume":"27","author":"Cloud","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib158","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-7825-0_16","article-title":"Magnetic resonance imaging in Huntington's disease","volume":"1780","author":"Gregory","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib159","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-801893-4.00021-3","article-title":"Functional imaging in Huntington disease","volume":"144","author":"Niethammer","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib160","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bpa.12426","article-title":"Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain","volume":"26","author":"R\u00fcb","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib161","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14737175.2018.1403899","article-title":"Treatment options for chorea","volume":"18","author":"Bashir","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib162","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.55.6.800","article-title":"Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese","volume":"55","author":"Gwinn-Hardy","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib163","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.1997.00550210011007","article-title":"Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds","volume":"54","author":"Sch\u00f6ls","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib164","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/mds.10241","article-title":"Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians","volume":"17","author":"Subramony","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib165","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1212\/WNL.48.2.482","article-title":"Machado-Joseph disease in four Chinese pedigrees: molecular analysis of 15 patients including two juvenile cases and clinical correlations","volume":"48","author":"Zhou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib166","first-page":"1","article-title":"Parkinsonism in spinocerebellar ataxia","volume":"2015","author":"Park","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib167","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ene.12350","article-title":"Autosomal dominant cerebellar ataxias: a systematic review of clinical features","volume":"21","author":"Rossi","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib168","unstructured":"H. Paulson, Spinocerebellar Ataxia Type 3, Adam MP, Ardinger HH, Al Pagon RA , Ed. GeneReviews\u00ae [Internet]. Seattle Univ. Washington, Seattle; 1993-2019. (n.d.). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1196\/(accessed January 23, 2019)."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib169","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40673-016-0042-6","article-title":"Patterns of motor signs in spinocerebellar ataxia type 3 at the start of follow-up in a reference unit","volume":"3","author":"Pulido-Valdeolivas","year":"2016","journal-title":"Cerebellum & Ataxias"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.parkreldis.2017.08.012","article-title":"DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism","volume":"44","author":"Miyaue","year":"2017","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.14802\/jmd.15009","article-title":"Untangling the thorns: advances in the neuroacanthocytosis syndromes","volume":"8","author":"Walker","year":"2015","journal-title":"J. Mov. Disord."},{"issue":"Pt 1A","key":"10.1016\/j.parkreldis.2019.06.025_bib172","first-page":"13","article-title":"Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases","volume":"114","author":"Hardie","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib173","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.23971","article-title":"Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings, and treatment considerations","volume":"27","author":"Schneider","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib174","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mds.10650","article-title":"Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration","volume":"19","author":"Thomas","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib175","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1007\/s00415-012-6521-7","article-title":"C19orf12 mutations in neurodegeneration with brain iron accumulation mimicking juvenile amyotrophic lateral sclerosis","volume":"259","author":"Deschauer","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib176","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/mds.25410","article-title":"Clinical features of neurodegeneration with brain iron accumulation due to a C19orf12 gene mutation","volume":"28","author":"Goldman","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib177","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","article-title":"Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation","volume":"89","author":"Hartig","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib178","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000000577","article-title":"Levodopa-induced dyskinesias in mitochondrial membrane protein-associated neurodegeneration","volume":"9","author":"Savitt","year":"2019","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib179","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajhg.2013.11.008","article-title":"Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation","volume":"94","author":"Dusi","year":"2014","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.parkreldis.2016.03.011","article-title":"Mutational analysis of COASY in an Italian patient with NBIA","volume":"28","author":"Annesi","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib181","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/ajmg.a.38252","article-title":"Diagnosis of CoPAN by whole exome sequencing: waking up a sleeping tiger's eye","volume":"173","author":"Evers","year":"2017","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib182","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5334\/tohm.317","article-title":"Neuroferritinopathy: pathophysiology, presentation, differential diagnoses and management","volume":"6","author":"Kumar","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib183","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00415-009-0083-3","article-title":"SPG11 spastic paraplegia","volume":"256","author":"Anheim","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib184","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00415-013-7216-4","article-title":"SPG15: a cause of juvenile atypical levodopa responsive parkinsonism","volume":"261","author":"Mallaret","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.parkreldis.2004.05.003","article-title":"Levodopa-responsive parkinsonism in hereditary spastic paraplegia with thin corpus callosum","volume":"10","author":"Kang","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib186","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mdc3.12144","article-title":"SPG11 mutations associated with a complex phenotype resembling dopa-responsive dystonia","volume":"2","author":"Wijemanne","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib187","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/mds.26828","article-title":"A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification","volume":"31","author":"Shi","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib188","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mdc3.12573","article-title":"The spectrum of movement disorders in childhood-onset lysosomal storage diseases","volume":"5","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"5","key":"10.1016\/j.parkreldis.2019.06.025_bib189","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/mds.27568","article-title":"Movement disorders in treatable inborn errors of metabolism (epub ahead of print)","volume":"34","author":"Ebrahimi-Fakhari","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib190","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3389\/fneur.2018.00857","article-title":"Parkinsonism in inherited metabolic disorders: key considerations and major features","volume":"9","author":"Limphaibool","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib191","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.spen.2018.02.003","article-title":"Movement disorders and neurometabolic diseases","volume":"25","author":"Christensen","year":"2018","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib192","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mds.870030403","article-title":"The diverse neurological features of Niemann-Pick disease type C: a report of two cases","volume":"3","author":"Coleman","year":"1988","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib193","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.54.5.1069","article-title":"Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms","volume":"54","author":"Aberg","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib194","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mdc3.12111","article-title":"Parkinsonism and other movement disorders associated with Chediak-Higashi syndrome: case report and systematic literature review","volume":"2","author":"Balint","year":"2015","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib195","series-title":"GeneReviews\u00ae [Internet]","article-title":"Cerebrotendinous xanthomatosis","author":"Federico","year":"1993"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib196","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/mds.22313","article-title":"Spectrum of movement disorders associated with glutaric aciduria type 1: a study of 16 patients","volume":"23","author":"Gitiaux","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib197","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/088307389601100314","article-title":"Parkinsonian manifestations in a patient with homocystinuria","volume":"11","author":"Keskin","year":"1996","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib198","series-title":"GeneReviews\u00ae [Internet]","article-title":"SLC6A3-Related dopamine transporter deficiency syndrome","author":"Kurian","year":"2017"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib199","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/mds.26966","article-title":"Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease","volume":"32","author":"Giannoccaro","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z","article-title":"A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism\/MELAS overlap syndrome","volume":"45","author":"De Coo","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib201","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.parkreldis.2016.06.013","article-title":"Juvenile onset Parkinsonism with \u201cpure nigral\u201d degeneration and POLG1 mutation","volume":"30","author":"Mehta","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib202","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/mds.20559","article-title":"Neuronal intranuclear inclusion disease: report on a case originally diagnosed as dopa-responsive dystonia with Lewy bodies","volume":"20","author":"Paviour","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib203","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/BF00690510","article-title":"A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection","volume":"10","author":"Lindenberg","year":"1968","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib204","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/1531-8257(200009)15:5<990::AID-MDS1035>3.0.CO;2-I","article-title":"Neuronal intranuclear inclusion disease and juvenile parkinsonism","volume":"15","author":"O'Sullivan","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-510X(98)00169-5","article-title":"Familial neuronal intranuclear inclusion disease with ubiquitin positive inclusions","volume":"160","author":"Kimber","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib206","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/mds.22876","article-title":"Neuronal intranuclear inclusion disease: two cases of dopa-responsive juvenile parkinsonism with drug-induced dyskinesia","volume":"25","author":"Lai","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib207","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/mds.23194","article-title":"Juvenile levodopa-responsive Parkinsonism with early orobuccolingual dyskinesias and cognitive impairment","volume":"25","author":"Espay","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib208","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/S031716710000994X","article-title":"Neuronal intranuclear inclusion disease presenting as juvenile parkinsonism","volume":"37","author":"Wiltshire","year":"2010","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib209","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14737175.2019.1569515","article-title":"Approaching drug-induced parkinsonism from a neurohospitalist perspective","volume":"19","author":"Margolesky","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib210","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib211","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/JCP.0000000000000419","article-title":"Neurological adverse effects of antipsychotics in children and adolescents","volume":"35","author":"Garcia-Amador","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: an update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib213","series-title":"Handb. Clin. Neurol.","first-page":"1235","article-title":"Immune-mediated extrapyramidal movement disorders, including Sydenham chorea","author":"Dale","year":"2013"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib214","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.spen.2017.08.003","article-title":"Autoantibody-associated movement disorders in children: proven and proposed","volume":"24","author":"Singer","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib215","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/mds.25354","article-title":"The spectrum of movement disorders in children with anti-NMDA receptor encephalitis","volume":"28","author":"Baizabal-Carvallo","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib216","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejpn.2018.01.012","article-title":"Pediatric NMDAR encephalitis: a single center observation study with a closer look at movement disorders","volume":"22","author":"Granata","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib217","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.seizure.2018.12.015","article-title":"EEG findings in NMDA encephalitis \u2013 a systematic review","volume":"65","author":"Gillinder","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib218","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/brain\/awh008","article-title":"Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity","volume":"127","author":"Dale","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib219","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.21807","article-title":"N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica","volume":"66","author":"Dale","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib220","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1093\/brain\/aws256","article-title":"Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders","volume":"135","author":"Dale","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib221","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpn.2007.11.005","article-title":"From juvenile parkinsonism to encephalitis lethargica, a new phenotype of post-streptococcal disorders: case report","volume":"12","author":"Beleza","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib222","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jnen\/60.7.696","article-title":"Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases","volume":"60","author":"McCall","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib223","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"120","author":"Baizabal-Carvallo","year":"2013","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib224","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0961203307081421","article-title":"Unusual neurologic manifestations (I): parkinsonism in juvenile SLE","volume":"16","author":"Khubchandani","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib225","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib226","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/mds.10288","article-title":"Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature","volume":"17","author":"Garc\u00eda-Moreno","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib227","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2334-13-179","article-title":"Post-dengue parkinsonism","volume":"13","author":"Azmin","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib228","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/INF.0000000000000382","article-title":"Post-dengue encephalopathy and parkinsonism, Pediatr","volume":"33","author":"Fong","year":"2014","journal-title":"Inf. Disp. J."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib229","doi-asserted-by":"crossref","DOI":"10.1177\/0883073813510741","article-title":"Transient parkinsonism following Mycoplasma pneumoniae infection with normal brain magnetic resonance imaging (MRI)","volume":"29","author":"Tay","year":"2014","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib230","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.870100419","article-title":"Reversible parkinsonism and dystonia following probable mycoplasma pneumoniae infection","volume":"10","author":"Kim","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib231","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.parkreldis.2005.11.004","article-title":"Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report","volume":"12","author":"Roselli","year":"2006","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib232","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mds.20742","article-title":"Acute reversible parkinsonism in Epstein-Bbarr virus-related encephalitis lethargica-like illness","volume":"21","author":"Dimova","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib233","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib234","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00415-010-5659-4","article-title":"Spectrum of movement disorders in encephalitis","volume":"257","author":"Misra","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib235","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.braindev.2015.02.008","article-title":"Subacute sclerosing panencephalitis with parkinsonian features in a child: a case report","volume":"37","author":"Bozlu","year":"2015","journal-title":"Brain Dev."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib236","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/0028-3886.152678","article-title":"Subacute sclerosing panencephalitis masquerading as rapid-onset dystonia-Parkinsonism in a child","volume":"63","author":"Gulati","year":"2015","journal-title":"Neurol. India"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib237","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bjid.2016.05.008","article-title":"Parkinsonism in HIV infected patients during antiretroviral therapy \u2013 data from a Brazilian tertiary hospital","volume":"20","author":"Dehner","year":"2016","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib238","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.870070213","article-title":"Postvaccinal parkinsonism","volume":"7","author":"Alves","year":"1992","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib239","doi-asserted-by":"crossref","DOI":"10.1176\/appi.neuropsych.11110324","article-title":"Acute onset of parkinsonism with reversible course after H1N1 vaccination: insight from a young lady","volume":"24","author":"Yeh","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib240","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2011.03469.x","article-title":"A clinical profile of 103 patients with secondary movement disorders: correlation of etiology with phenomenology","volume":"19","author":"Netravathi","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib241","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8257(199909)14:5<842::AID-MDS1020>3.0.CO;2-O","article-title":"Parkinsonism in children resulting from mesencephalic tumors","volume":"14","author":"Pohle","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib242","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000121382","article-title":"Resting tremor secondary to a pineal cyst: case report and review of the literature","volume":"44","author":"Morgan","year":"2008","journal-title":"Pediatr. Neurosurg."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib243","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0887-8994(94)90045-0","article-title":"Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder","volume":"10","author":"Pranzatelli","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib244","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mds.870090503","article-title":"Parkinsonian syndromes associated with hydrocephalus: case reports, a review of the literature, and pathophysiological hypotheses","volume":"9","author":"Curran","year":"1994","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pediatrneurol.2005.10.021","article-title":"Secondary parkinsonism in childhood: a rare complication after radiotherapy","volume":"34","author":"Voermans","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib246","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1469-8749.1993.tb11584.x","article-title":"Delayed parkinsonism associated with hypotension in a child undergoing open-heart surgery","volume":"35","author":"Straussberg","year":"1993","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib247","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/mpo.10111","article-title":"Secondary parkinsonism: an unusual late complication of craniospinal radiotherapy given to a 16-month child","volume":"40","author":"Skiming","year":"2003","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib248","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s007020050215","article-title":"Extrapontine myelinolysis with parkinsonism after rapid correction of hyponatremia: high cerebrospinal fluid level of homovanillic acid and successful dopaminergic treatment","volume":"106","author":"Nagamitsu","year":"1999","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib249","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s00415-013-7162-1","article-title":"Juvenile parkinsonism as an initial manifestation of gliomatosis cerebri","volume":"260","author":"Jang","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.27534","article-title":"Pathogenesis-targeted therapeutic strategies in Parkinson's disease","volume":"34","author":"Jankovic","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib251","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0037-1601888","article-title":"Diagnosis and management of Parkinson's disease","volume":"37","author":"Tarakad","year":"2017","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib252","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamaneurol.2017.0348","article-title":"Common myths in the use of levodopa in Parkinson disease: when clinical trials misinform clinical practice","volume":"74","author":"Espay","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib253","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005816","article-title":"DIGPD Study Group, Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib254","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/toxins10070299","article-title":"Botulinum toxin for the treatment of hand tremor","volume":"10","author":"Niemann","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1092852917000608","article-title":"Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes","volume":"22","author":"Stahl","year":"2017","journal-title":"CNS Spectr."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib256","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/pgs-2018-0188","article-title":"Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective","volume":"20","author":"Legge","year":"2019","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.parkreldis.2019.06.025_bib257","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S1092852916000407","article-title":"Mechanism of action of pimavanserin in Parkinson's disease psychosis: targeting serotonin 5HT2A and 5HT2C receptors","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib258","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/dmcn.14063","article-title":"Deep brain stimulation for pediatric dystonia: a meta\u2010analysis with individual participant data","volume":"61","author":"Elkaim","year":"2019","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib259","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00381-018-3839-1","article-title":"DBS in pediatric patients: institutional experience","volume":"34","author":"Canaz","year":"2018","journal-title":"Child\u2019s Nerv. Syst."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib260","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3171\/2011.8.PEDS11153","article-title":"Deep brain stimulation in children: experience and technical pearls","volume":"8","author":"Air","year":"2011","journal-title":"J. Neurosurg. Pediatr."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib261","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7800","article-title":"Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease: a systematic review and meta-analysis","volume":"2","author":"Artusi","year":"2019","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib262","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mdc3.12309","article-title":"Consortium on risk for early onset Parkinson's disease (CORE-PD) investigators, genetic and clinical predictors of deep brain stimulation in young-onset Parkinson's disease","volume":"3","author":"Pal","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.parkreldis.2019.06.025_bib263","article-title":"Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease (epub ahead of print)","author":"Rizzone","year":"2018","journal-title":"Park. Relat. Disord"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019302883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:17:13Z","timestamp":1761178633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019302883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":263,"alternative-id":["S1353802019302883"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.025","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile parkinsonism: Differential diagnosis, genetics, and treatment","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}